LADENBURG THALMANN FINANCIAL SERVICES INC. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 250 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$72,000
+380.0%
3,015
+480.9%
0.00%
Q3 2019$15,000
-59.5%
519
-54.0%
0.00%
Q2 2019$37,000
-11.9%
1,129
-4.6%
0.00%
Q1 2019$42,000
-10.6%
1,184
-16.7%
0.00%
Q4 2018$47,000
+20.5%
1,421
+85.5%
0.00%
Q3 2018$39,000
-56.7%
766
-60.8%
0.00%
-100.0%
Q2 2018$90,0000.0%1,9550.0%0.00%0.0%
Q1 2018$90,000
+40.6%
1,955
+23.7%
0.00%0.0%
Q4 2017$64,000
-14.7%
1,581
-14.8%
0.00%0.0%
Q3 2017$75,000
-15.7%
1,856
-10.3%
0.00%0.0%
Q2 2017$89,000
+11.2%
2,070
-18.6%
0.00%0.0%
Q1 2017$80,000
+11.1%
2,544
-11.2%
0.00%0.0%
Q4 2016$72,000
+9.1%
2,865
+5.4%
0.00%0.0%
Q3 2016$66,000
-13.2%
2,718
-27.2%
0.00%0.0%
Q2 2016$76,000
+35.7%
3,734
+1.2%
0.00%0.0%
Q1 2016$56,000
+86.7%
3,690
+67.1%
0.00%0.0%
Q4 2015$30,000
-18.9%
2,208
-16.7%
0.00%0.0%
Q3 2015$37,000
-17.8%
2,651
+1.0%
0.00%0.0%
Q2 2015$45,000
+200.0%
2,626
+116.8%
0.00%
Q1 2015$15,000
+50.0%
1,2110.0%0.00%
Q4 2014$10,000
-9.1%
1,2110.0%0.00%
Q3 2014$11,000
-15.4%
1,2110.0%0.00%
Q2 2014$13,000
+44.4%
1,211
+21.1%
0.00%
Q1 2014$9,000
+12.5%
1,0000.0%0.00%
Q4 2013$8,0001,0000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
NEA Management Company, LLC 7,641,250$107,207,0007.06%
HealthInvest Partners AB 782,746$10,982,0006.50%
KOPP INVESTMENT ADVISORS LLC 729,960$10,241,0005.51%
Murphy Michael R 1,028,304$14,427,0004.96%
Opaleye Management Inc. 460,000$6,454,0003.18%
ASHFORD CAPITAL MANAGEMENT INC 511,244$7,173,0001.68%
Bruce & Co., Inc. 394,581$5,535,0001.42%
AlphaOne Investment Services, LLC 235,065$3,297,0001.40%
Ranger Investment Management 1,560,453$21,893,0001.23%
NORTHPOINTE CAPITAL LLC 584,753$8,204,0001.07%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders